Study of Subretinally Injected SAR439483 Administered in Patients With Leber Congenital Amaurosis Caused by Biallelic Mutations in GUCY2D

Condition:   Leber's Congenital Amaurosis Interventions:   Drug: SAR439483;   Drug: SAR439483 Diluent Solution;   Drug: Prednisone;   Drug: Triamcinalone Acetonide;   Drug: 1% Prednisolone;   Drug: Trimethoprim/polymyxin B Sponsor:   Sanofi Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials